WormBase Tree Display for RNAi: WBRNAi00071168
expand all nodes | collapse all nodes | view schema
| WBRNAi00071168 | Homol | Homol_homol | T09A5:RNAi | ||
|---|---|---|---|---|---|
| Sequence_info | PCR_product | sjj_T09A5.5 | |||
| Experiment | Laboratory | RT | |||
| Date | 16 Jul 2007 00:00:00 | ||||
| Genotype | bIs1(vit-2::GFP); rrf-3(pk1426) | ||||
| Temperature | 20 | ||||
| Delivered_by | Bacterial_feeding | ||||
| Inhibits | Predicted_gene | T09A5.5 | Inferred_automatically | RNAi_primary | |
| Gene | WBGene00011634 | Inferred_automatically | RNAi_primary | ||
| Transcript | T09A5.5.1 | Inferred_automatically | RNAi_primary | ||
| Species | Caenorhabditis elegans | ||||
| Reference | WBPaper00030951 | ||||
| Phenotype | WBPhenotype:0000961 | Remark | RNAi treatment resulted in an abnormal accumulation of YP170-GFP in the body cavity. | ||
| WBPhenotype:0001425 | Remark | RNAi treatment resulted in weak suppression of yolk uptake by oocytes as judged by the abnormal accumulation of YP170-GFP in the body cavity. | |||
| Remark | Primary screen. L1 larval stage was applied to induced RNAi cultures. | ||||
| Method | RNAi |
